Home/Filings/4/0001209191-23-014438
4//SEC Filing

Inbar Galia 4

Accession 0001209191-23-014438

CIK 0000818686other

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 7:35 AM ET

Size

7.6 KB

Accession

0001209191-23-014438

Insider Transaction Report

Form 4
Period: 2023-02-28
Inbar Galia
See "Remarks"
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2023-02-28+4,82820,194 total
  • Exercise/Conversion

    Restricted Share Units

    2023-02-284,8284,829 total
    Ordinary Shares (4,828 underlying)
Footnotes (3)
  • [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
  • [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
  • [F3]Restricted share units were granted on February 28, 2020 with 4,828 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 4,829 vesting on February 28, 2024.

Issuer

TEVA PHARMACEUTICAL INDUSTRIES LTD

CIK 0000818686

Entity typeother

Related Parties

1
  • filerCIK 0001878086

Filing Metadata

Form type
4
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:35 AM ET
Size
7.6 KB